|
ARWR | Arrowhead Pharmaceuticals, Inc. |
|
|
ARWR | Arrowhead Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.07 |
| Leverage | 64.57% |
| Market Cap | $ 7.8B |
| PE | 39.23 |
| Dividend Yield | 0.00% |
| Profit | $ 198.7m |
| Margin | 18.27% |
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.